|
SE9501384D0
(sv)
|
1995-04-13 |
1995-04-13 |
Astra Ab |
Process for the preparation of respirable particles
|
|
SE9701956D0
(sv)
|
1997-05-23 |
1997-05-23 |
Astra Ab |
New composition of matter
|
|
ID24063A
(id)
*
|
1997-06-27 |
2000-07-06 |
Astra Ab |
Kombinasi obat anti asma
|
|
SE9704186D0
(sv)
|
1997-11-14 |
1997-11-14 |
Astra Ab |
New composition of matter
|
|
GB9806477D0
(en)
*
|
1998-03-26 |
1998-05-27 |
Glaxo Group Ltd |
Improved crystals
|
|
GB2341120B
(en)
|
1998-09-04 |
2002-04-17 |
Aea Technology Plc |
Controlling uniformity of crystalline precipitates
|
|
SE9803770D0
(sv)
*
|
1998-11-05 |
1998-11-05 |
Astra Ab |
Dry powder pharmaceutical formulation
|
|
SE9804001D0
(sv)
*
|
1998-11-23 |
1998-11-23 |
Astra Ab |
New process
|
|
GB9826284D0
(en)
*
|
1998-12-01 |
1999-01-20 |
Rhone Poulence Rorer Limited |
Process
|
|
GB9826286D0
(en)
*
|
1998-12-01 |
1999-01-20 |
Rhone Poulence Rorer Limited |
Process
|
|
GB9828721D0
(en)
*
|
1998-12-24 |
1999-02-17 |
Glaxo Group Ltd |
Novel apparatus and process
|
|
GB9905512D0
(en)
*
|
1999-03-10 |
1999-05-05 |
Smithkline Beecham Plc |
Process
|
|
GB9919693D0
(en)
*
|
1999-08-19 |
1999-10-20 |
Rhone Poulenc Rorer Ltd |
Process
|
|
YU34501A
(sh)
|
2000-05-26 |
2003-10-31 |
Pfizer Products Inc. |
Postupak reaktivne kristalizacije radi povećanja veličine čestica
|
|
GB0016002D0
(en)
*
|
2000-06-29 |
2000-08-23 |
Glaxo Group Ltd |
Novel process for preparing crystalline particles
|
|
GB0015981D0
(en)
*
|
2000-06-29 |
2000-08-23 |
Glaxo Group Ltd |
Novel process for preparing crystalline particles
|
|
GB0016040D0
(en)
*
|
2000-06-29 |
2000-08-23 |
Glaxo Group Ltd |
Novel process for preparing crystalline particles
|
|
US9700866B2
(en)
*
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
|
US20050048126A1
(en)
*
|
2000-12-22 |
2005-03-03 |
Barrett Rabinow |
Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
|
|
US20040256749A1
(en)
*
|
2000-12-22 |
2004-12-23 |
Mahesh Chaubal |
Process for production of essentially solvent-free small particles
|
|
US6951656B2
(en)
|
2000-12-22 |
2005-10-04 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
|
US6884436B2
(en)
*
|
2000-12-22 |
2005-04-26 |
Baxter International Inc. |
Method for preparing submicron particle suspensions
|
|
US8067032B2
(en)
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
|
US6667344B2
(en)
|
2001-04-17 |
2003-12-23 |
Dey, L.P. |
Bronchodilating compositions and methods
|
|
US20030055026A1
(en)
|
2001-04-17 |
2003-03-20 |
Dey L.P. |
Formoterol/steroid bronchodilating compositions and methods of use thereof
|
|
JP2004530545A
(ja)
|
2001-05-05 |
2004-10-07 |
アクセンタス パブリック リミテッド カンパニー |
微小結晶の形成方法および装置
|
|
DE10137017A1
(de)
*
|
2001-07-30 |
2003-02-20 |
Basf Ag |
Kristallisationsverfahren zur Einstellung kleiner Partikel
|
|
ATE336231T1
(de)
*
|
2001-08-29 |
2006-09-15 |
Dow Global Technologies Inc |
Verfahren zur herstellung kristalliner arzneimittelteilchen durch ausfällung
|
|
IL160570A0
(en)
*
|
2001-09-26 |
2004-07-25 |
Baxter Int |
Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
|
|
US20060003012A9
(en)
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
|
US7931022B2
(en)
*
|
2001-10-19 |
2011-04-26 |
Respirks, Inc. |
Method and apparatus for dispensing inhalator medicament
|
|
US7112340B2
(en)
*
|
2001-10-19 |
2006-09-26 |
Baxter International Inc. |
Compositions of and method for preparing stable particles in a frozen aqueous matrix
|
|
US20030191151A1
(en)
*
|
2001-10-26 |
2003-10-09 |
Imtiaz Chaudry |
Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
|
|
US20030140920A1
(en)
*
|
2001-10-26 |
2003-07-31 |
Dey L.P. |
Albuterol inhalation soultion, system, kit and method for relieving symptoms of pediatric asthma
|
|
US20030203930A1
(en)
*
|
2001-10-26 |
2003-10-30 |
Imtiaz Chaudry |
Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
|
|
JP2003221335A
(ja)
|
2001-10-26 |
2003-08-05 |
Dey Lp |
慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法
|
|
US6702997B2
(en)
|
2001-10-26 |
2004-03-09 |
Dey, L.P. |
Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
|
|
SI1476201T1
(sl)
|
2002-02-19 |
2009-06-30 |
Resolution Chemicals Ltd |
Sterilizacija steroidov, osnovana na topilu
|
|
DE10214031A1
(de)
*
|
2002-03-27 |
2004-02-19 |
Pharmatech Gmbh |
Verfahren zur Herstellung und Anwendung von Mikro- und Nanoteilchen durch aufbauende Mikronisation
|
|
FI20020857A
(fi)
*
|
2002-05-07 |
2003-11-08 |
Focus Inhalation Oy |
Amorfisen aineen muuntaminen vastaavaksi kiteiseksi aineeksi spraykuivaamalla ja käyttämällä kiteistä spraykuivattua ainetta lääkevalmisteissa
|
|
AU2003280102B2
(en)
*
|
2002-06-28 |
2007-01-25 |
Alkermes, Inc. |
Inhalable epinephrine
|
|
GB0216700D0
(en)
|
2002-07-18 |
2002-08-28 |
Astrazeneca Ab |
Process
|
|
US20040023935A1
(en)
*
|
2002-08-02 |
2004-02-05 |
Dey, L.P. |
Inhalation compositions, methods of use thereof, and process for preparation of same
|
|
US20040028747A1
(en)
*
|
2002-08-06 |
2004-02-12 |
Tucker Christopher J. |
Crystalline drug particles prepared using a controlled precipitation process
|
|
US20040028746A1
(en)
*
|
2002-08-06 |
2004-02-12 |
Sonke Svenson |
Crystalline drug particles prepared using a controlled precipitation (recrystallization) process
|
|
JP2006503865A
(ja)
*
|
2002-09-30 |
2006-02-02 |
アキュスフィア， インコーポレイテッド |
吸入のための徐放性の多孔性微粒子
|
|
US20040109826A1
(en)
*
|
2002-12-06 |
2004-06-10 |
Dey, L.P. |
Stabilized albuterol compositions and method of preparation thereof
|
|
US20040121003A1
(en)
*
|
2002-12-19 |
2004-06-24 |
Acusphere, Inc. |
Methods for making pharmaceutical formulations comprising deagglomerated microparticles
|
|
US6962006B2
(en)
*
|
2002-12-19 |
2005-11-08 |
Acusphere, Inc. |
Methods and apparatus for making particles using spray dryer and in-line jet mill
|
|
WO2004066912A2
(en)
*
|
2003-01-31 |
2004-08-12 |
Technion Research & Development Foundation Ltd. |
Anti-inflammatory compositions and uses thereof
|
|
GB0302673D0
(en)
|
2003-02-06 |
2003-03-12 |
Astrazeneca Ab |
Pharmaceutical formulations
|
|
PE20040950A1
(es)
|
2003-02-14 |
2005-01-01 |
Theravance Inc |
DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
|
|
EP1610878B1
(en)
*
|
2003-02-21 |
2014-09-03 |
University Of Bath |
Process for the production of particles
|
|
US7041144B2
(en)
*
|
2003-03-04 |
2006-05-09 |
Five Star Technologies, Inc. |
Hydrodynamic cavitation crystallization process
|
|
US7511079B2
(en)
*
|
2003-03-24 |
2009-03-31 |
Baxter International Inc. |
Methods and apparatuses for the comminution and stabilization of small particles
|
|
AU2004234057A1
(en)
*
|
2003-04-29 |
2004-11-11 |
Akzo Nobel N.V. |
Antisolvent solidification process
|
|
JP4622855B2
(ja)
*
|
2003-06-10 |
2011-02-02 |
大正製薬株式会社 |
放射球状晶析物およびその製造方法並びにこれを利用するドライパウダー製剤
|
|
SE0302029D0
(sv)
*
|
2003-07-07 |
2003-07-07 |
Astrazeneca Ab |
Novel process
|
|
TWI359675B
(en)
|
2003-07-10 |
2012-03-11 |
Dey L P |
Bronchodilating β-agonist compositions
|
|
EP1711163A2
(en)
*
|
2004-02-05 |
2006-10-18 |
Baxter International Inc. |
Dispersions prepared by use of self-stabilizing agents
|
|
TWI341836B
(en)
|
2004-03-11 |
2011-05-11 |
Theravance Inc |
Biphenyl compounds useful as muscarinic receptor antagonists
|
|
US7968575B2
(en)
*
|
2004-05-05 |
2011-06-28 |
Renopharm Ltd. |
Nitric oxide donors and uses thereof
|
|
US8134010B2
(en)
*
|
2004-05-05 |
2012-03-13 |
Renopharm Ltd. |
Thiazole-based nitric oxide donors having aryl substituent(s) and uses thereof
|
|
EP1753734A1
(en)
*
|
2004-05-05 |
2007-02-21 |
Renopharm Ltd. |
Nitric oxide donors and uses thereof
|
|
US7498445B2
(en)
*
|
2004-05-05 |
2009-03-03 |
Renopharm Ltd. |
Thiazole-based nitric oxide donors capable of releasing two or more nitric oxide molecules and uses thereof
|
|
US20070231398A1
(en)
*
|
2004-05-05 |
2007-10-04 |
Van Lare Cornelis E J |
Antisolvent Emulsion Solidification Process
|
|
US20060009435A1
(en)
*
|
2004-06-23 |
2006-01-12 |
Joseph Kaspi |
Synthesis and powder preparation of fluticasone propionate
|
|
JP2008510015A
(ja)
|
2004-08-16 |
2008-04-03 |
セラヴァンス， インコーポレーテッド |
β２アドレナリン作用性レセプターアゴニスト活性およびムスカリン性レセプターアンタゴニスト活性を有する化合物
|
|
WO2006045795A2
(en)
*
|
2004-10-29 |
2006-05-04 |
Akzo Nobel N.V. |
Processes involving the use of antisolvent crystallization
|
|
US20060120972A1
(en)
*
|
2004-11-09 |
2006-06-08 |
Peter Engels |
9-(N-methyl-piperidyliden-4)-thioxanthene for treatment of pulmonary hypertension
|
|
DE102005011786A1
(de)
*
|
2005-03-11 |
2006-09-14 |
Pharmasol Gmbh |
Verfahren zur Herstellung ultrafeiner Submicron-Suspensionen
|
|
JP2008533055A
(ja)
*
|
2005-03-18 |
2008-08-21 |
ナノマテリアルズ テクノロジー ピーティーイー リミテッド |
吸入剤
|
|
EP1868577A4
(en)
|
2005-04-15 |
2009-12-09 |
Reddys Lab Inc Dr |
Lacidipine PARTICLE
|
|
US20060280787A1
(en)
*
|
2005-06-14 |
2006-12-14 |
Baxter International Inc. |
Pharmaceutical formulation of the tubulin inhibitor indibulin for oral administration with improved pharmacokinetic properties, and process for the manufacture thereof
|
|
AU2006269961B2
(en)
*
|
2005-07-15 |
2012-07-19 |
Map Pharmaceuticals, Inc. |
Multiple active pharmaceutical ingredients combined in discrete inhalation particles and formulations thereof
|
|
US8475845B2
(en)
*
|
2005-07-15 |
2013-07-02 |
Map Pharmaceuticals, Inc. |
Method of particle formation
|
|
WO2007014393A2
(en)
*
|
2005-07-28 |
2007-02-01 |
Isp Investments Inc. |
Amorphous efavirenz and the production thereof
|
|
US20070099883A1
(en)
*
|
2005-10-07 |
2007-05-03 |
Cheryl Lynn Calis |
Anhydrous mometasone furoate formulation
|
|
JP2009516003A
(ja)
*
|
2005-11-15 |
2009-04-16 |
バクスター・インターナショナル・インコーポレイテッド |
リポキシゲナーゼ阻害剤の組成物
|
|
WO2007070851A2
(en)
*
|
2005-12-15 |
2007-06-21 |
Acusphere, Inc. |
Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration
|
|
EP1978933A2
(en)
*
|
2005-12-15 |
2008-10-15 |
Acusphere, Inc. |
Processes for making particle-based pharmaceutical formulations for oral administration
|
|
US7913223B2
(en)
*
|
2005-12-16 |
2011-03-22 |
Dialogic Corporation |
Method and system for development and use of a user-interface for operations, administration, maintenance and provisioning of a telecommunications system
|
|
US20080085315A1
(en)
*
|
2006-10-10 |
2008-04-10 |
John Alfred Doney |
Amorphous ezetimibe and the production thereof
|
|
WO2008057048A1
(en)
*
|
2006-11-09 |
2008-05-15 |
Nanomaterials Technology Pte Ltd |
Nano & micro-sized particles of statin compounds and process for forming same
|
|
US20080152717A1
(en)
*
|
2006-12-14 |
2008-06-26 |
Isp Investments, Inc. |
Amorphous valsartan and the production thereof
|
|
US8613946B2
(en)
*
|
2006-12-21 |
2013-12-24 |
Isp Investment Inc. |
Carotenoids of enhanced bioavailability
|
|
US20090152176A1
(en)
*
|
2006-12-23 |
2009-06-18 |
Baxter International Inc. |
Magnetic separation of fine particles from compositions
|
|
WO2008092046A2
(en)
*
|
2007-01-26 |
2008-07-31 |
Isp Investments Inc. |
Amorphous oxcarbazepine and the production thereof
|
|
US10189957B2
(en)
*
|
2007-01-26 |
2019-01-29 |
Isp Investments Llc |
Formulation process method to produce spray dried products
|
|
US20080293814A1
(en)
*
|
2007-05-22 |
2008-11-27 |
Deepak Tiwari |
Concentrate esmolol
|
|
US8722736B2
(en)
*
|
2007-05-22 |
2014-05-13 |
Baxter International Inc. |
Multi-dose concentrate esmolol with benzyl alcohol
|
|
US8426467B2
(en)
*
|
2007-05-22 |
2013-04-23 |
Baxter International Inc. |
Colored esmolol concentrate
|
|
EP2191821A1
(en)
*
|
2008-11-26 |
2010-06-02 |
CHIESI FARMACEUTICI S.p.A. |
Microparticles comprising a salt of 8-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1H)-quinolinone having improved adhesion properties for dry powder inhalation
|
|
US8236862B2
(en)
*
|
2009-02-06 |
2012-08-07 |
University Of Southern California |
Therapeutic compositions comprising monoterpenes
|
|
US20100291221A1
(en)
*
|
2009-05-15 |
2010-11-18 |
Robert Owen Cook |
Method of administering dose-sparing amounts of formoterol fumarate-budesonide combination particles by inhalation
|
|
US20100298602A1
(en)
*
|
2009-05-19 |
2010-11-25 |
Massachusetts Institute Of Technology |
Systems and methods for microfluidic crystallization
|
|
US20100294986A1
(en)
*
|
2009-05-19 |
2010-11-25 |
Massachusetts Institute Of Technology |
Supercritical fluid facilitated particle formation in microfluidic systems
|
|
CA2989129C
(en)
|
2009-07-15 |
2021-03-09 |
Theravance Biopharma R&D Ip, Llc |
Crystalline freebase forms of a biphenyl compound
|
|
CN102573886A
(zh)
*
|
2009-09-17 |
2012-07-11 |
相互制药公司 |
用抗病毒剂治疗哮喘的方法
|
|
KR20120104975A
(ko)
*
|
2009-10-01 |
2012-09-24 |
앱탈리스 파마테크, 인코포레이티드 |
경구 투여용 코르티코스테로이드 조성물
|
|
MX338211B
(es)
|
2009-10-22 |
2016-03-30 |
Api Genesis Llc |
Metodos para hacer y utilizar composiciones que comprenden flavonoides.
|
|
BR112012022209A2
(pt)
|
2010-03-03 |
2017-06-06 |
Neonc Tech Inc |
composições farmacêuticas compreendendo monoterpenos
|
|
CN101849910B
(zh)
*
|
2010-05-18 |
2012-02-22 |
重庆华邦制药股份有限公司 |
一种二丙酸倍他米松微粒的制备方法
|
|
ES2600928T3
(es)
|
2010-08-27 |
2017-02-13 |
Neonc Technologies Inc. |
Composiciones farmacéuticas que comprenden derivados de alcohol perilílico
|
|
US20160038600A1
(en)
|
2012-08-03 |
2016-02-11 |
Neonc Technologies Inc. |
Pharmaceutical compositions comprising poh derivatives
|
|
US8574630B2
(en)
|
2010-09-22 |
2013-11-05 |
Map Pharmaceuticals, Inc. |
Corticosteroid particles and method of production
|
|
EP4374929A3
(en)
|
2010-12-17 |
2024-08-07 |
University of Southern California |
Methods and devices for using isoperillyl alcohol
|
|
CN102134236B
(zh)
*
|
2011-04-15 |
2013-07-24 |
北方民族大学 |
微细克拉霉素粉体的制备方法
|
|
AU2012282936B2
(en)
*
|
2011-07-08 |
2016-11-10 |
Pfizer Limited |
Process for the preparation of fluticasone propionate form 1
|
|
WO2013053696A1
(en)
|
2011-10-11 |
2013-04-18 |
Chiesi Farmaceutici S.P.A. |
Crystalline microparticles of a beta-agonist coated with a fatty acid
|
|
DE102012221219B4
(de)
*
|
2012-11-20 |
2014-05-28 |
Jesalis Pharma Gmbh |
Verfahren zur Vergrößerung der Partikelgröße kristalliner Wirkstoff-Mikropartikel
|
|
CN105142638B
(zh)
|
2013-03-15 |
2020-08-28 |
维罗纳制药公司 |
药物组合
|
|
SI3142701T1
(en)
|
2014-05-12 |
2018-08-31 |
Verona Pharma Plc |
NEW TREATMENT
|
|
WO2016007682A1
(en)
*
|
2014-07-08 |
2016-01-14 |
Amphastar Pharmaceuticals Inc. |
Micronized insulin, micronized insulin analogues, and methods of manufacturing the same
|
|
AU2016219257B2
(en)
|
2015-02-12 |
2020-06-25 |
University Of Southern California |
Pharmaceutical compositions comprising perillyl alcohol derivatives
|
|
US10322168B2
(en)
|
2016-01-07 |
2019-06-18 |
Amphastar Pharmaceuticals, Inc. |
High-purity inhalable particles of insulin and insulin analogues, and high-efficiency methods of manufacturing the same
|
|
TWI777515B
(zh)
|
2016-08-18 |
2022-09-11 |
美商愛戴爾製藥股份有限公司 |
治療嗜伊紅性食道炎之方法
|
|
JP7144411B2
(ja)
|
2016-11-30 |
2022-09-29 |
ネオンク テクノロジーズ インク． |
ペリリルアルコール－３－ブロモピルベート複合体及びがんの治療方法
|
|
DK3749291T3
(da)
|
2018-02-08 |
2024-04-08 |
Univ Southern California |
Fremgangsmåder til permeabilisering af blod-hjerne-barrieren
|
|
WO2020205539A1
(en)
|
2019-03-29 |
2020-10-08 |
Vizuri Health Sciences Consumer Healthcare, Inc. |
Compositions and methods for the prevention and treatment of radiation dermatitis, eczema, burns, wounds and certain cancers
|
|
CN114262316A
(zh)
*
|
2021-12-24 |
2022-04-01 |
嘉应学院 |
纳米橙皮素、其制备方法及所用双匀浆空化射流系统
|